ARTICLE

Coronavirus: U.S. begins 2 trials testing Eli Lilly's coronavirus antibody drug

- CNBC (2020)

The trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech company AbCellera.

saved by: FoundryBase
updated about 2 months ago
Visibility: Public (all visitors)


View All Articles

Comments

No comments yet. Be the first to comment!

Related Chunks

Related chunks with this resource

This Article can be found in 1 chunk
Eli Lilly - Antibody injections - a leading candidate for COVID19 Coronavirus cure, treatment
Antibody injections, treatment - a leading candidate for COVID19 Coronavirus cure
FoundryBase 6 resources

MORE RESOURCES FROM SOURCE

More in FoundryBase from   CNBC